|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q43886070
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235751.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q43886070
|
|
024
|
|
|
‡a
0000-0002-7770-7376
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q43886070
|
|
100
|
0 |
|
‡a
Jia-Yi Li
‡9
sl
|
|
400
|
0 |
|
‡a
Jia-Yi Li
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Jia-Yi Li
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Jia-Yi Li
‡c
investigador/a
‡9
es
|
|
400
|
0 |
|
‡a
Jia-Yi Li
‡c
investigador
‡9
ast
|
|
670
|
|
|
‡a
Author's A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
|
|
670
|
|
|
‡a
Author's Abundant expression of zinc transporters in Bergman glia of mouse cerebellum
|
|
670
|
|
|
‡a
Author's Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
|
|
670
|
|
|
‡a
Author's Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.
|
|
670
|
|
|
‡a
Author's Adrenergic differentiation and SSR2a receptor expression in CAD-cells cultured in serum-free medium.
|
|
670
|
|
|
‡a
Author's Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
|
|
670
|
|
|
‡a
Author's Axonal transport of neuropeptides: Retrograde tracing study in live cell cultures of rat sympathetic cervical ganglia
|
|
670
|
|
|
‡a
Author's Axonopathy in Huntington's disease.
|
|
670
|
|
|
‡a
Author's Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats
|
|
670
|
|
|
‡a
Author's By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
|
|
670
|
|
|
‡a
Author's Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
|
|
670
|
|
|
‡a
Author's Cholinergic neuronal defect without cell loss in Huntington's disease
|
|
670
|
|
|
‡a
Author's Critical issues of clinical human embryonic stem cell therapy for brain repair
|
|
670
|
|
|
‡a
Author's Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
|
|
670
|
|
|
‡a
Author's Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction
|
|
670
|
|
|
‡a
Author's Derivation of mouse embryonic stem cell lines from tyrosine hydroxylase reporter mice crossed with a human SNCA transgenic mouse model of Parkinson's disease.
|
|
670
|
|
|
‡a
Author's Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
|
|
670
|
|
|
‡a
Author's Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
|
|
670
|
|
|
‡a
Author's Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3
|
|
670
|
|
|
‡a
Author's Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats
|
|
670
|
|
|
‡a
Author's Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
|
|
670
|
|
|
‡a
Author's Failure of transdifferentiation of adult hematopoietic stem cells into neurons
|
|
670
|
|
|
‡a
Author's From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
|
|
670
|
|
|
‡a
Author's Fungal acetylome comparative analysis identifies an essential role of acetylation in human fungal pathogen virulence
|
|
670
|
|
|
‡a
Author's GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2.
|
|
670
|
|
|
‡a
Author's Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
|
|
670
|
|
|
‡a
Author's Huntington's disease: a synaptopathy?
|
|
670
|
|
|
‡a
Author's Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
|
|
670
|
|
|
‡a
Author's Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis
|
|
670
|
|
|
‡a
Author's Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
|
|
670
|
|
|
‡a
Author's Localization of zinc-enriched neurons in the mouse peripheral sympathetic system
|
|
670
|
|
|
‡a
Author's Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
|
|
670
|
|
|
‡a
Author's Microbiome changes: an indicator of Parkinson's disease?
|
|
670
|
|
|
‡a
Author's Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion
|
|
670
|
|
|
‡a
Author's Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis
|
|
670
|
|
|
‡a
Author's Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells
|
|
670
|
|
|
‡a
Author's Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats
|
|
670
|
|
|
‡a
Author's "NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells
|
|
670
|
|
|
‡a
Author's NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease.
|
|
670
|
|
|
‡a
Author's No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington's disease
|
|
670
|
|
|
‡a
Author's Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons
|
|
670
|
|
|
‡a
Author's Orexin loss in Huntington's disease.
|
|
670
|
|
|
‡a
Author's Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy
|
|
670
|
|
|
‡a
Author's Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis.
|
|
670
|
|
|
‡a
Author's Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
|
|
670
|
|
|
‡a
Author's Restorative cell therapy for Parkinson's disease: a quest for the perfect cell
|
|
670
|
|
|
‡a
Author's Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease
|
|
670
|
|
|
‡a
Author's SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells
|
|
670
|
|
|
‡a
Author's The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1
|
|
670
|
|
|
‡a
Author's The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis
|
|
670
|
|
|
‡a
Author's Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation
|
|
909
|
|
|
‡a
(orcid) 0000000277707376
‡9
1
|
|
919
|
|
|
‡a
localizationofzincenrichedneuronsinthemouseperipheralsympatheticsystem
‡A
Localization of zinc-enriched neurons in the mouse peripheral sympathetic system
‡9
1
|
|
919
|
|
|
‡a
lossofsnap25andrabphilin3ainsensorymotorcortexinhuntingtonsdisease
‡A
Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
‡9
1
|
|
919
|
|
|
‡a
microbiomechangesanindicatorofparkinsonsdisease
‡A
Microbiome changes: an indicator of Parkinson's disease?
‡9
1
|
|
919
|
|
|
‡a
mutanthuntingtininteractswithbetatubulinanddisruptsvesiculartransportandinsulinsecretion
‡A
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion
‡9
1
|
|
919
|
|
|
‡a
neurogenin2directsgranuleneuroblastproductionandamplificationwhileneurod1specifiesneuronalfateduringhippocampalneurogenesis
‡A
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis
‡9
1
|
|
919
|
|
|
‡a
huntingtonsdiseaseasynaptopathy
‡A
Huntington's disease: a synaptopathy?
‡9
1
|
|
919
|
|
|
‡a
generationandcharacterizationofnovelconformationspecificmonoclonalantibodiesforαsynucleinpathology
‡A
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
‡9
1
|
|
919
|
|
|
‡a
gabaergicdifferentiationinducedbymash1iscompromisedbythebhlhproteinsneurogenin2neurod1andneurod2
‡A
GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2.
‡9
1
|
|
919
|
|
|
‡a
fungalacetylomecomparativeanalysisidentifiesanessentialroleofacetylationinhumanfungalpathogenvirulence
‡A
Fungal acetylome comparative analysis identifies an essential role of acetylation in human fungal pathogen virulence
‡9
1
|
|
919
|
|
|
‡a
frombenchtobedthepotentialofstemcellsforthetreatmentofparkinsonsdisease
‡A
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
‡9
1
|
|
919
|
|
|
‡a
failureoftransdifferentiationofadulthematopoieticstemcellsintoneurons
‡A
Failure of transdifferentiation of adult hematopoietic stem cells into neurons
‡9
1
|
|
919
|
|
|
‡a
extensivegraftderiveddopaminergicinnervationismaintained24yearsaftertransplantationinthedegeneratingparkinsonianbrain
‡A
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
‡9
1
|
|
919
|
|
|
‡a
neuronalpropertiesinvivoeffectsandpathologyofahuntingtonsdiseasepatientderivedinducedpluripotentstemcells
‡A
Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells
‡9
1
|
|
919
|
|
|
‡a
neuropeptidey2receptorsareinvolvedinenhancedneurogenicvasoconstrictioninspontaneouslyhypertensiverats
‡A
Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats
‡9
1
|
|
919
|
|
|
‡a
neurostemchipanovelhighlyspecializedtooltostudyneuraldifferentiationpathwaysinhumanstemcells
‡A
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells
‡9
1
|
|
919
|
|
|
‡a
ngfrescueshippocampalcholinergicneuronalmarkersrestoresneurogenesisandimprovesthespatialworkingmemoryinamousemodelofhuntingtonsdisease
‡A
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease.
‡9
1
|
|
919
|
|
|
‡a
nosymphonywithoutbassoonandpiccolochangesinsynapticactivezoneproteinsinhuntingtonsdisease
‡A
No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
novelaavbasedratmodelofforebrainsynucleinopathyshowsextensivepathologiesandprogressivelossofcholinergicinterneurons
‡A
Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons
‡9
1
|
|
919
|
|
|
‡a
orexinlossinhuntingtonsdisease
‡A
Orexin loss in Huntington's disease.
‡9
1
|
|
919
|
|
|
‡a
plaqueassociatedlipidsinalzheimersdiseasedbraintissuevisualizedbynonlinearmicroscopy
‡A
Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy
‡9
1
|
|
919
|
|
|
‡a
reciprocalfunctionsofcryptococcusneoformanscopperhomeostasismachineryduringpulmonaryinfectionandmeningoencephalitis
‡A
Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis.
‡9
1
|
|
919
|
|
|
‡a
reducedhippocampalneurogenesisinr62transgenichuntingtonsdiseasemice
‡A
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
‡9
1
|
|
919
|
|
|
‡a
restorativecelltherapyforparkinsonsdiseaseaquestfortheperfectcell
‡A
Restorative cell therapy for Parkinson's disease: a quest for the perfect cell
‡9
1
|
|
919
|
|
|
‡a
signsofdegenerationin1222yearoldgraftsofmesencephalicdopamineneuronsinpatientswithparkinsonsdisease
‡A
Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease
‡9
1
|
|
919
|
|
|
‡a
ssr2areceptorexpressionandadrenergiccholinergiccharacteristicsindifferentiatedshsy5ycells
‡A
SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells
‡9
1
|
|
919
|
|
|
‡a
origindevelopmentandmoleculardiversityofrodentolfactorybulbglutamatergicneuronsdistinguishedbyexpressionoftranscriptionfactorneurod1
‡A
The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1
‡9
1
|
|
919
|
|
|
‡a
r62transgenicmousemodelofhuntingtonsdiseasedevelopsdiabetesduetodeficientbetacellmassandexocytosis
‡A
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis
‡9
1
|
|
919
|
|
|
‡a
transplantationofhumanembryonicstemcellderivedcellstoaratmodelofparkinsonsdiseaseeffectofinvitrodifferentiationongraftsurvivalandteratomaformation
‡A
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation
‡9
1
|
|
919
|
|
|
‡a
enhancedneuropeptideyimmunoreactivityandvasoconstrictioninmesentericsmallarteriesfromspontaneouslyhypertensiverats
‡A
Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats
‡9
1
|
|
919
|
|
|
‡a
effectsondifferentiationofembryonicventralmidbrainprogenitorsbylmx1amsx1ngn2andpitx3
‡A
Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3
‡9
1
|
|
919
|
|
|
‡a
directevidenceofparkinsonpathologyspreadfromthegastrointestinaltracttothebraininrats
‡A
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
‡9
1
|
|
919
|
|
|
‡a
dihydromyricetinandsalvianolicacidbinhibitalphasynucleinaggregationandenhancechaperonemediatedautophagy
‡A
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
‡9
1
|
|
919
|
|
|
‡a
derivationofmouseembryonicstemcelllinesfromtyrosinehydroxylasereportermicecrossedwithahumansncatransgenicmousemodelofparkinsonsdisease
‡A
Derivation of mouse embryonic stem cell lines from tyrosine hydroxylase reporter mice crossed with a human SNCA transgenic mouse model of Parkinson's disease.
‡9
1
|
|
919
|
|
|
‡a
depletionofrabphilin3ainatransgenicmousemodelr61ofhuntingtonsdiseaseapossibleculpritinsynapticdysfunction
‡A
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction
‡9
1
|
|
919
|
|
|
‡a
deferoxamineinhibitsironinducedhippocampaltauphosphorylationinthealzheimertransgenicmousebrain
‡A
Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
‡9
1
|
|
919
|
|
|
‡a
criticalissuesofclinicalhumanembryonicstemcelltherapyforbrainrepair
‡A
Critical issues of clinical human embryonic stem cell therapy for brain repair
‡9
1
|
|
919
|
|
|
‡a
cholinergicneuronaldefectwithoutcelllossinhuntingtonsdisease
‡A
Cholinergic neuronal defect without cell loss in Huntington's disease
‡9
1
|
|
919
|
|
|
‡a
characterizationoflewybodypathologyin12and16yearoldintrastriatalmesencephalicgraftssurvivinginapatientwithparkinsonsdisease
‡A
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
‡9
1
|
|
919
|
|
|
‡a
byactivatingmatrixmetalloproteinase7shearstresspromoteschondrosarcomacellmotilityinvasionandlungcolonization
‡A
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
‡9
1
|
|
919
|
|
|
‡a
bluntedpancreaticpolypeptideinducedvasodilatationinmesentericresistancevesselsfromspontaneouslyhypertensiverats
‡A
Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats
‡9
1
|
|
919
|
|
|
‡a
axonopathyinhuntingtonsdisease
‡A
Axonopathy in Huntington's disease.
‡9
1
|
|
919
|
|
|
‡a
axonaltransportofneuropeptidesretrogradetracingstudyinlivecellculturesofratsympatheticcervicalganglia
‡A
Axonal transport of neuropeptides: Retrograde tracing study in live cell cultures of rat sympathetic cervical ganglia
‡9
1
|
|
919
|
|
|
‡a
autonomicganglionicinjectionofαsynucleinfibrilsasamodelofpureautonomicfailureαsynucleinopathy
‡A
Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
‡9
1
|
|
919
|
|
|
‡a
adrenergicdifferentiationandssr2areceptorexpressionincadcellsculturedinserumfreemedium
‡A
Adrenergic differentiation and SSR2a receptor expression in CAD-cells cultured in serum-free medium.
‡9
1
|
|
919
|
|
|
‡a
activatingtranscriptionfactor6derepressionmediatesneuroprotectioninhuntingtondisease
‡A
Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.
‡9
1
|
|
919
|
|
|
‡a
accumulationofubiquitinconjugatesinapolyglutaminediseasemodeloccurswithoutglobalubiquitinproteasomesystemimpairment
‡A
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
‡9
1
|
|
919
|
|
|
‡a
abundantexpressionofzinctransportersinbergmangliaofmousecerebellum
‡A
Abundant expression of zinc transporters in Bergman glia of mouse cerebellum
‡9
1
|
|
919
|
|
|
‡a
simplemethodforlargescalegenerationofdopamineneuronsfromhumanembryonicstemcells
‡A
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
‡9
1
|
|
919
|
|
|
‡a
identificationofmoleculesderivedfromhumanfibroblastfeedercellsthatsupporttheproliferationofhumanembryonicstemcells
‡A
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
‡9
1
|
|
919
|
|
|
‡a
involvementofngn2tbrandneurodproteinsduringpostnatalolfactorybulbneurogenesis
‡A
Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis
‡9
1
|
|
919
|
|
|
‡a
lateonsetvasculardysfunctioninther61modelofhuntingtonsdisease
‡A
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
‡9
1
|
|
996
|
|
|
‡2
CAOONL|ncf11038952
|
|
996
|
|
|
‡2
LC|nr 94031755
|
|
996
|
|
|
‡2
SUDOC|191606979
|
|
996
|
|
|
‡2
CYT|AC000663285
|
|
996
|
|
|
‡2
CYT|AC000640051
|
|
996
|
|
|
‡2
CYT|AC000653296
|
|
996
|
|
|
‡2
CAOONL|ncf10403212
|
|
996
|
|
|
‡2
BIBSYS|1007742
|
|
996
|
|
|
‡2
CAOONL|ncf11511564
|
|
996
|
|
|
‡2
NKC|xx0224717
|
|
996
|
|
|
‡2
LC|n 82015527
|
|
996
|
|
|
‡2
CYT|AC000556660
|
|
996
|
|
|
‡2
DNB|118875485
|
|
996
|
|
|
‡2
ISNI|0000000063596973
|
|
996
|
|
|
‡2
CYT|AC000324344
|
|
996
|
|
|
‡2
NTA|207215286
|
|
996
|
|
|
‡2
SUDOC|032859155
|
|
996
|
|
|
‡2
ISNI|0000000064104272
|
|
996
|
|
|
‡2
CYT|AC000556449
|
|
996
|
|
|
‡2
CYT|AC000257556
|
|
996
|
|
|
‡2
ISNI|0000000064286109
|
|
996
|
|
|
‡2
ISNI|0000000064016029
|
|
996
|
|
|
‡2
CAOONL|ncf11864653
|
|
996
|
|
|
‡2
DNB|173492681
|
|
996
|
|
|
‡2
LC|n 84228459
|
|
996
|
|
|
‡2
NTA|426165594
|
|
996
|
|
|
‡2
LC|nr 99003344
|
|
996
|
|
|
‡2
J9U|987007441117505171
|
|
996
|
|
|
‡2
DNB|1315073005
|
|
996
|
|
|
‡2
LC|n 2020016516
|
|
996
|
|
|
‡2
CYT|AC000650477
|
|
996
|
|
|
‡2
CYT|AC000650473
|
|
996
|
|
|
‡2
CYT|AC000259353
|
|
996
|
|
|
‡2
LC|no2011049892
|
|
996
|
|
|
‡2
CYT|AC000258850
|
|
996
|
|
|
‡2
CYT|AC000258508
|
|
996
|
|
|
‡2
DNB|1323336362
|
|
996
|
|
|
‡2
CYT|AC000634293
|
|
996
|
|
|
‡2
LC|no2024102049
|
|
996
|
|
|
‡2
CYT|AC000003365
|
|
996
|
|
|
‡2
LC|n 88163121
|
|
996
|
|
|
‡2
CYT|AC000634001
|
|
996
|
|
|
‡2
BNF|16163659
|
|
996
|
|
|
‡2
CYT|AC000638742
|
|
996
|
|
|
‡2
ISNI|0000000426618327
|
|
996
|
|
|
‡2
CYT|AC000358118
|
|
996
|
|
|
‡2
ISNI|0000000063282819
|
|
996
|
|
|
‡2
ISNI|0000000364544982
|
|
996
|
|
|
‡2
LC|no 96047171
|
|
996
|
|
|
‡2
ISNI|0000000080207474
|
|
996
|
|
|
‡2
CYT|AC000660644
|
|
996
|
|
|
‡2
LC|n 85023660
|
|
996
|
|
|
‡2
CYT|AC000643577
|
|
996
|
|
|
‡2
BIBSYS|4085209
|
|
996
|
|
|
‡2
DNB|1138051101
|
|
996
|
|
|
‡2
NTA|353558036
|
|
996
|
|
|
‡2
CYT|AC000644506
|
|
996
|
|
|
‡2
ISNI|0000000107831446
|
|
996
|
|
|
‡2
BNF|15527533
|
|
996
|
|
|
‡2
CYT|AC000517267
|
|
996
|
|
|
‡2
DNB|1023070766
|
|
996
|
|
|
‡2
LC|n 2024000211
|
|
996
|
|
|
‡2
ISNI|0000000117052251
|
|
996
|
|
|
‡2
LC|n 82085269
|
|
996
|
|
|
‡2
ISNI|000000006431099X
|
|
996
|
|
|
‡2
ISNI|0000000063293104
|
|
996
|
|
|
‡2
DNB|1327955911
|
|
996
|
|
|
‡2
CYT|AC000633334
|
|
996
|
|
|
‡2
LC|n 2006096021
|
|
996
|
|
|
‡2
SUDOC|131934546
|
|
996
|
|
|
‡2
PLWABN|9810531390405606
|
|
996
|
|
|
‡2
ISNI|0000000385741432
|
|
996
|
|
|
‡2
PLWABN|9810679960505606
|
|
996
|
|
|
‡2
LC|nr 95018120
|
|
996
|
|
|
‡2
CYT|AC000419297
|
|
996
|
|
|
‡2
ISNI|0000000075390905
|
|
996
|
|
|
‡2
ISNI|0000000120302522
|
|
996
|
|
|
‡2
DNB|172695465
|
|
996
|
|
|
‡2
CYT|AC000408256
|
|
996
|
|
|
‡2
CYT|AC660426
|
|
996
|
|
|
‡2
CYT|AC000641921
|
|
996
|
|
|
‡2
LC|nr2002001586
|
|
996
|
|
|
‡2
LC|no2012075204
|
|
996
|
|
|
‡2
CYT|AC000636055
|
|
996
|
|
|
‡2
DNB|1182864821
|
|
996
|
|
|
‡2
ISNI|0000000080873805
|
|
996
|
|
|
‡2
DNB|105838354X
|
|
996
|
|
|
‡2
LC|n 81044444
|
|
996
|
|
|
‡2
LC|nr 94000502
|
|
996
|
|
|
‡2
NUKAT|n 2021209022
|
|
996
|
|
|
‡2
CYT|AC000258797
|
|
996
|
|
|
‡2
BIBSYS|90738495
|
|
996
|
|
|
‡2
CYT|AC000258790
|
|
996
|
|
|
‡2
LC|n 84198322
|
|
996
|
|
|
‡2
SELIBR|357671
|
|
996
|
|
|
‡2
NTA|323265480
|
|
996
|
|
|
‡2
CYT|AC000257605
|
|
996
|
|
|
‡2
LC|nr 88004894
|
|
996
|
|
|
‡2
DNB|1025827066
|
|
996
|
|
|
‡2
NTA|364154128
|
|
996
|
|
|
‡2
DNB|1046435329
|
|
996
|
|
|
‡2
CYT|AC000622487
|
|
996
|
|
|
‡2
NUKAT|n 2021211153
|
|
996
|
|
|
‡2
J9U|987007345960405171
|
|
996
|
|
|
‡2
LNB|LNC10-000200799
|
|
996
|
|
|
‡2
CYT|AC000216377
|
|
996
|
|
|
‡2
CYT|AC000216376
|
|
996
|
|
|
‡2
ISNI|0000000063467178
|
|
996
|
|
|
‡2
LC|n 90694804
|
|
996
|
|
|
‡2
LC|n 90643389
|
|
996
|
|
|
‡2
ISNI|0000000074185846
|
|
996
|
|
|
‡2
ISNI|0000000063569895
|
|
996
|
|
|
‡2
LC|n 2003002518
|
|
996
|
|
|
‡2
CYT|AC000655418
|
|
996
|
|
|
‡2
DNB|1141181096
|
|
996
|
|
|
‡2
CYT|AC000652681
|
|
996
|
|
|
‡2
ISNI|0000000067869617
|
|
996
|
|
|
‡2
LC|n 82010430
|
|
996
|
|
|
‡2
NDL|001273800
|
|
996
|
|
|
‡2
ISNI|0000000449240806
|
|
996
|
|
|
‡2
ISNI|0000000063943373
|
|
996
|
|
|
‡2
CYT|AC000257410
|
|
996
|
|
|
‡2
SUDOC|185979564
|
|
996
|
|
|
‡2
ISNI|0000000004717165
|
|
996
|
|
|
‡2
CYT|AC000661905
|
|
996
|
|
|
‡2
SUDOC|152295070
|
|
996
|
|
|
‡2
LC|no2008046070
|
|
996
|
|
|
‡2
ISNI|0000000063686813
|
|
996
|
|
|
‡2
CYT|AC000650725
|
|
996
|
|
|
‡2
DNB|1171868162
|
|
996
|
|
|
‡2
CYT|AC000662626
|
|
996
|
|
|
‡2
CAOONL|ncf11699329
|
|
996
|
|
|
‡2
LC|n 95111498
|
|
996
|
|
|
‡2
DNB|1066599823
|
|
996
|
|
|
‡2
CYT|AC000257785
|
|
996
|
|
|
‡2
ISNI|0000000063490167
|
|
996
|
|
|
‡2
CYT|AC000257789
|
|
996
|
|
|
‡2
NTA|364170166
|
|
996
|
|
|
‡2
CYT|AC000643142
|
|
996
|
|
|
‡2
SUDOC|142881082
|
|
996
|
|
|
‡2
LC|n 84005339
|
|
996
|
|
|
‡2
LC|n 2015190633
|
|
996
|
|
|
‡2
J9U|987007438656105171
|
|
996
|
|
|
‡2
NUKAT|n 2009105351
|
|
996
|
|
|
‡2
CYT|AC000658480
|
|
996
|
|
|
‡2
ISNI|0000000064330181
|
|
996
|
|
|
‡2
LC|n 86079767
|
|
996
|
|
|
‡2
ISNI|0000000106025282
|
|
996
|
|
|
‡2
CYT|AC000314883
|
|
996
|
|
|
‡2
LC|nr 94011417
|
|
996
|
|
|
‡2
LC|n 79092082
|
|
996
|
|
|
‡2
CAOONL|ncf10084563
|
|
996
|
|
|
‡2
CYT|AC000657031
|
|
996
|
|
|
‡2
CAOONL|ncf10287867
|
|
996
|
|
|
‡2
CYT|AC000259212
|
|
996
|
|
|
‡2
LC|n 83159289
|
|
996
|
|
|
‡2
DNB|17330401X
|
|
996
|
|
|
‡2
ISNI|0000000054508652
|
|
996
|
|
|
‡2
CYT|AC000259266
|
|
996
|
|
|
‡2
CYT|AC000259264
|
|
996
|
|
|
‡2
CYT|AC000259263
|
|
996
|
|
|
‡2
CYT|AC000259261
|
|
996
|
|
|
‡2
CYT|AC000216929
|
|
996
|
|
|
‡2
LC|n 86098896
|
|
996
|
|
|
‡2
BNF|12515745
|
|
996
|
|
|
‡2
KRNLK|KAC200704836
|
|
996
|
|
|
‡2
DNB|1237844401
|
|
996
|
|
|
‡2
PLWABN|9812800956105606
|
|
996
|
|
|
‡2
CYT|AC000569204
|
|
996
|
|
|
‡2
CYT|AC000569205
|
|
996
|
|
|
‡2
CYT|AC000569203
|
|
996
|
|
|
‡2
DNB|122907744
|
|
996
|
|
|
‡2
DNB|119537907
|
|
996
|
|
|
‡2
BNF|16196167
|
|
996
|
|
|
‡2
SUDOC|191653098
|
|
996
|
|
|
‡2
CYT|AC000356973
|
|
996
|
|
|
‡2
CYT|AC000258034
|
|
996
|
|
|
‡2
LC|n 83001387
|
|
996
|
|
|
‡2
CYT|AC000653469
|
|
996
|
|
|
‡2
CYT|AC000258030
|
|
996
|
|
|
‡2
CYT|AC000507102
|
|
996
|
|
|
‡2
LC|n 97077086
|
|
996
|
|
|
‡2
DNB|173244041
|
|
996
|
|
|
‡2
PLWABN|9810686115305606
|
|
996
|
|
|
‡2
CYT|AC000634884
|
|
996
|
|
|
‡2
ISNI|0000000063458079
|
|
996
|
|
|
‡2
CYT|AC000567019
|
|
996
|
|
|
‡2
CYT|AC000652622
|
|
996
|
|
|
‡2
CYT|AC000567153
|
|
996
|
|
|
‡2
BIBSYS|90672096
|
|
996
|
|
|
‡2
CYT|AC000639705
|
|
996
|
|
|
‡2
ISNI|0000000044793322
|
|
996
|
|
|
‡2
DNB|1256848433
|
|
996
|
|
|
‡2
LC|no2016040290
|
|
996
|
|
|
‡2
NTA|33590369X
|
|
996
|
|
|
‡2
ISNI|0000000063624911
|
|
996
|
|
|
‡2
CYT|AC000503905
|
|
996
|
|
|
‡2
CYT|AC000503907
|
|
996
|
|
|
‡2
DNB|1045567523
|
|
996
|
|
|
‡2
LC|n 81025852
|
|
996
|
|
|
‡2
ISNI|0000000458722786
|
|
996
|
|
|
‡2
BNF|11912939
|
|
996
|
|
|
‡2
CYT|AC000514772
|
|
996
|
|
|
‡2
CYT|AC000514773
|
|
996
|
|
|
‡2
SUDOC|189045973
|
|
996
|
|
|
‡2
SUDOC|170034836
|
|
996
|
|
|
‡2
ISNI|0000000079937656
|
|
996
|
|
|
‡2
DNB|119138123
|
|
996
|
|
|
‡2
BNF|17956522
|
|
996
|
|
|
‡2
CYT|AC000643297
|
|
996
|
|
|
‡2
BIBSYS|32507
|
|
996
|
|
|
‡2
ISNI|0000000445504333
|
|
996
|
|
|
‡2
CYT|AC000661489
|
|
996
|
|
|
‡2
DNB|1068406976
|
|
996
|
|
|
‡2
ISNI|0000000075579206
|
|
996
|
|
|
‡2
LC|nr 95041230
|
|
996
|
|
|
‡2
CYT|AC000258713
|
|
996
|
|
|
‡2
LC|n 82243234
|
|
996
|
|
|
‡2
ISNI|0000000036426186
|
|
996
|
|
|
‡2
CYT|AC000258010
|
|
996
|
|
|
‡2
PLWABN|9811727856305606
|
|
996
|
|
|
‡2
DNB|1319573673
|
|
996
|
|
|
‡2
NTA|327885025
|
|
996
|
|
|
‡2
CYT|AC000258787
|
|
996
|
|
|
‡2
DNB|1155595467
|
|
996
|
|
|
‡2
CYT|AC000258371
|
|
996
|
|
|
‡2
LC|n 2001099645
|
|
996
|
|
|
‡2
CYT|AC000510593
|
|
996
|
|
|
‡2
LC|n 00012732
|
|
996
|
|
|
‡2
CYT|AC000510594
|
|
996
|
|
|
‡2
DNB|1341752402
|
|
996
|
|
|
‡2
DNB|1254063099
|
|
996
|
|
|
‡2
CYT|AC000258652
|
|
996
|
|
|
‡2
BNF|16580018
|
|
996
|
|
|
‡2
LC|n 81079066
|
|
996
|
|
|
‡2
CYT|AC000007838
|
|
996
|
|
|
‡2
SUDOC|149502648
|
|
996
|
|
|
‡2
NYNYRILM|394132
|
|
996
|
|
|
‡2
LC|n 78067639
|
|
996
|
|
|
‡2
DNB|1251279104
|
|
996
|
|
|
‡2
ISNI|0000000371182326
|
|
996
|
|
|
‡2
BNF|15881939
|
|
996
|
|
|
‡2
LC|n 2008024143
|
|
996
|
|
|
‡2
CYT|AC000216384
|
|
996
|
|
|
‡2
DNB|1245961489
|
|
996
|
|
|
‡2
ISNI|0000000082323508
|
|
996
|
|
|
‡2
ISNI|0000000002271323
|
|
996
|
|
|
‡2
CYT|AC660161
|
|
996
|
|
|
‡2
ISNI|0000000122467275
|
|
996
|
|
|
‡2
CYT|AC000591387
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
